This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Image: Kamaria Moore-Hollis (left) and her mother…
In a new mice study, researchers showed that beta-amyloid — the toxic protein linked to Alzheimer’s — can gum up the olfactory system and…
With a strong family history of Alzheimer’s, Dewayne Nash had expected that he would start experiencing symptoms of the disease by the time he…
New animal studies hint that non-hallucinogenic psychedelics could help reduce the toll of stress on the brain. Researchers at the University of California Santa…
While drug developers are heads down in the lab working to find medical treatments to slow the progression of Alzheimer’s, one tech company is…
From the nature of Alzheimer’s to the solutions available for controlling it, here are five common misconceptions to dispel. Alzheimer’s is the sixth leading…
Early research shows that consistent use of saunas or hot tubs may offer similar health benefits to traditional aerobic exercise — including lowering a…
Scientists still don’t know why some people develop Alzheimer’s and others don’t. But while we may not fully understand the causes of Alzheimer’s, researchers…
Cassava Sciences revealed positive clinical data from their simufilam trial, a potentially disease-modifying therapy for treating Alzheimer’s. Their preliminary study showed that simufilam significantly…
A dementia diagnosis puts into question people’s sense of personhood — what it means to be a person — in recognition that their ability…
Nicotine, a natural product of various plants including the tobacco plant, is notorious for its addictive properties in tobacco products like cigarettes. But the…
Dementia-friendly communities, or age-friendly cities, are defined by the World Health Organization as places where healthcare, socializing and security are adapted to those in…
The COVID-19 pandemic has taken a toll on all of us, but for people living with dementia and their families, the public health crisis…
Lack of diversity in clinical trials for Alzheimer’s and other diseases is hurting research, experts say. New data offers some solutions. New research presented…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Sheri Yarbrough sat across from her parents…